ACQUIRED C1 INHIBITOR DEFICIENCY

This adverse event was reported 21 times

These drugs are most commonly taken by patients reporting ACQUIRED C1 INHIBITOR DEFICIENCY:

# Drug Count
0 RITUXIMAB 9
1 BENDAMUSTINE HCL 4
2 VALSARTAN 4
3 VALSARTAN ORAL 4
4 ENALAPRIL 3
5 RAMIPRIL 3
6 ZANUBRUTINIB 2
7 AAMLODIPINE AND OLMESARTAN MEDOXOMIL 1
8 ACYCLOVIR 1
9 AMLODIPINE 1
See all common drugs associated with ACQUIRED C1 INHIBITOR DEFICIENCY

ACQUIRED C1 INHIBITOR DEFICIENCY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 AAMLODIPINE AND OLMESARTAN MEDOXOMIL 1 0.0049
1 ZANUBRUTINIB 2 0.0004
2 SUGAMMADEX 1 0.0004
3 BENDAMUSTINE HCL 4 0.0003
4 IMMUNE GLOBULIN INFUSION (HUMAN), 10% WITH RECOMBINANT HUMAN HYALURONIDASE 1 0.0002
5 IMMUNE GLOBULIN INFUSION (HUMAN) 1 0.0001
6 ROCURONIUM BROMIDE 1 0.0001
7 ENALAPRIL 3 0.0001
8 RITUXIMAB 9 0.0000
9 RAMIPRIL 3 0.0000
See all drugs enriched for association with ACQUIRED C1 INHIBITOR DEFICIENCY